Aerie Pharmaceuticals announces full exercise by initial purchasers of option
Aerie announced the initial purchasers of the previously announced offering of Aerie’s 1.50% Convertible Senior Notes due 2024 in a private offering to qualified institutional buyers have elected to fully exercise their option to purchase an additional $41.25 million of the notes. September 11, 2019